Does MOMELOTINIB Cause Myelofibrosis? 51 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 51 reports of Myelofibrosis have been filed in association with MOMELOTINIB (Ojjaara). This represents 5.6% of all adverse event reports for MOMELOTINIB.
51
Reports of Myelofibrosis with MOMELOTINIB
5.6%
of all MOMELOTINIB reports
11
Deaths
10
Hospitalizations
How Dangerous Is Myelofibrosis From MOMELOTINIB?
Of the 51 reports, 11 (21.6%) resulted in death, 10 (19.6%) required hospitalization.
Is Myelofibrosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MOMELOTINIB. However, 51 reports have been filed with the FAERS database.
What Other Side Effects Does MOMELOTINIB Cause?
Thrombocytopenia (89)
Death (77)
Drug ineffective (75)
Anaemia (59)
Diarrhoea (51)
Condition aggravated (49)
Dizziness (41)
Pneumonia (41)
Fatigue (39)
Platelet count decreased (38)
What Other Drugs Cause Myelofibrosis?
RUXOLITINIB (1,316)
ELTROMBOPAG (89)
ROMIPLOSTIM (89)
HYDROXYUREA (88)
IMATINIB (76)
DEFERASIROX (57)
ASPIRIN (46)
RITUXIMAB (43)
ANAGRELIDE (41)
ELTROMBOPAG OLAMINE (39)
Which MOMELOTINIB Alternatives Have Lower Myelofibrosis Risk?
MOMELOTINIB vs MOMETASONE
MOMELOTINIB vs MOMETASONE FUROATE
MOMELOTINIB vs MOMETASONE FUROATE\OLOPATADINE
MOMELOTINIB vs MONOMETHYL
MOMELOTINIB vs MONTELUKAST